Skip to main content
Clinical Trials/NCT01457534
NCT01457534CompletedNot Applicable

The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient

Yonsei University1 site in 1 country148 target enrollmentStarted: January 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
148
Locations
1
Primary Endpoint
the amount of ascites

Study Overview

Brief Summary

Background. Acute renal failure after liver transplantation (LT) requiring continuous renal replacement therapy (CRRT) adversely affects patient survival. However, there are few reports to assess the predictors for postoperative CRRT in liver transplant patients. The investigators undertook this study to identify perioperative factors that would predict patients at risk of CRRT.

Patients and Methods. The investigators retrospectively reviewed the data of 148 liver transplant patients from January 2007 to November 2010 at Severance Hospital, Yonsei University HealthSystem, in Seoul, Korea. The number of patients treated with CRRT was 44 (18 patients from living and 26 from deceased donors) and those without CRRT was 104. Univariate and stepwise logistic multivariate analyses were performed.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
19 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 19-65 year
  • Liver transplant patients from January 2008 to December 2011

Exclusion Criteria

  • Patients treated with CRRT before transplantation

Outcomes

Primary Outcomes

the amount of ascites

Time Frame: intraoperative

Intraoperative urine output

Time Frame: intraoperative

the duration of anesthesia and operation

Time Frame: intraoperative

intraoperative hemodynamic instability

Time Frame: intraoperative

intraoperative bleeding

Time Frame: intraoperative

status before operation

Time Frame: 1 day before operation

laboratory data(ex : total bilirubin, albumin, coagulation factors, blood gas analysis(arterial CO2 pressure. Blood urea nitrate/Creatinine, Hemoglobin/Hematocrit.)

the types of donation(living or deceased donor)

Time Frame: intraoperative

survival rate

Time Frame: on the postoperative 28th days, 365 days

postoperative bleeding amount

Time Frame: on the postoperative 28th days, 365 days.

postoperative CRRT(continuous renal replacement therapy),

Time Frame: on the postoperative 28th days, 365days

mortality

Time Frame: on the postoperative 28th days, 365 days.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

The Predictors for Continuous Renal... | Clinical Trial